Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04641871
Title Sym021 in Combination With Either Sym022 or Sym023 in Patients With Advanced Solid Tumor Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Symphogen A/S
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | CAN

Facility Status City State Zip Country Details
University of Colorado Aurora Colorado 80045 United States Details
Mayo Clinic - Jacksonville Jacksonville Florida 32224 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
University of Chicago Chicago Illinois 60637-1470 United States Details
University of Kansas Medical Center (KUMC) Westwood Kansas 66205 United States Details
START Midwest Grand Rapids Michigan 49546 United States Details
Mayo Clinic Rochester Minnesota 55902 United States Details
Montefiore Medical Center PRIME Bronx New York 10461 United States Details
Mount Sinai - PRIME New York New York 10029 United States Details
University of Cincinnati Medical Center Cincinnati Ohio 45267 United States Details
MD Anderson Houston Texas 77230 United States Details
Virginia Cancer Specialists, PC Fairfax Virginia 22031 United States Details
Princess Margaret Cancer Centre Toronto Ontario M5G 1X5 Canada Details
Centre Georges-François Leclerc, Department of Medical Oncology Dijon 21000 France Details
Institut de Cancerologie de L'Ouest Saint-Herblain 44805 France Details
Vall d'Hebron Institute of Oncology Barcelona 08035 Spain Details
Hospital Universitario San Carlos Madrid 28040 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field